Alexandre Duvignaud

7PUBLICATIONS
25CO-AUTHORS
Foetal development and medicineDisease surveillanceInfant and child healthAged health careMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 15, 2026
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial.

|May 12, 2025
Paradigm Shift Toward "One Health" Monitoring of Culex-Borne Arbovirus Circulation in France: The 2022 Inaugural Spotlight on West Nile and Usutu Viruses in Nouvelle-Aquitaine.

Gaëlle Gonzalez, Camille Victoire Migné, Alexandre Duvignaud

|Aug 21, 2024
Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE).

Alexandre Duvignaud, Ijeoma C Etafo, Marie Jaspard

|Jul 02, 2024
Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis.

Alexandre Duvignaud, Rhett J Stoney, Kristina M Angelo

|Oct 14, 2020
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).

Alexandre Duvignaud, Edouard Lhomme, Thierry Pistone

|Nov 14, 2017
Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program.

Mariame Camara, Eric Ouattara, Alexandre Duvignaud

Pageof 2

Frequent Collaborators

1 joint publications

Rhett J Stoney

1 joint publications

Daniel L Bourque

1 joint publications

Bhawana Amatya

1 joint publications

Francesca F Norman